FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

32505111000001109: Xadago 100mg tablets (Zambon UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-May 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2177181000001114 Xadago 100mg tablets (Zambon UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2177191000001111 Xadago 100mg tablets (Zambon UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xadago 100mg tablets (Zambon UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xadago 100mg tablets (Zambon UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Xadago 100mg tablets (Zambon UK Ltd) Is a Safinamide 100mg tablets true Inferred relationship Existential restriction modifier
Xadago 100mg tablets (Zambon UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xadago 100mg tablets (Zambon UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xadago 100mg tablets (Zambon UK Ltd) Has specific active ingredient Safinamide methansulfonate true Inferred relationship Existential restriction modifier
Xadago 100mg tablets (Zambon UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Xadago 100mg tablets (Zambon UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Safinamide false Inferred relationship Existential restriction modifier
Xadago 100mg tablets (Zambon UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xadago 100mg tablets (Zambon UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Xadago 100mg tablets (Zambon UK Ltd) Is a Xadago true Inferred relationship Existential restriction modifier
Xadago 100mg tablets (Zambon UK Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Xadago 100mg tablets (Zambon UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Safinamide true Inferred relationship Existential restriction modifier
Xadago 100mg tablets (Zambon UK Ltd) Has basis of strength substance Safinamide true Inferred relationship Existential restriction modifier
Xadago 100mg tablets (Zambon UK Ltd) Has active ingredient Substance with monoamine oxidase B inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Xadago 100mg tablets (Zambon UK Ltd) 30 tablet 3 x 10 tablets Has AMP True Xadago 100mg tablets (Zambon UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start